Hanyang University ERICA Opens 'Drug Metabolism Microbiomics Research Center'
Hanyang University ERICA announced on the 2nd that it has opened the 'Drug Metabolism Microbiomics Research Center' and will engage in related research and development as well as human resource training.
Officials are taking a commemorative photo at the "Drug Metabolism Microbiomics Research Center Opening Ceremony" held at the College of Pharmacy, Hanyang University ERICA.
[Photo by Hanyang University ERICA]
The research center was established to elucidate the interactions between the microbiome (microorganisms), which has recently gained attention in the pharmaceutical bio industry, and drugs, aiming to propose optimal drug therapy strategies. To this end, 13 participating researchers with expertise and research capabilities in pharmacokinetics, pharmacodynamics, and microbiomics, along with 60 students and researchers, are involved.
Additionally, the research center includes Seegene Medical Foundation, a molecular diagnostics specialist institution, and J2H Biotech, a synthetic drug new drug development specialist institution, to conduct joint research for the successful clinical application of basic research.
President Lee Ki-jung said, "Although the ERICA College of Pharmacy has a relatively short history, it has been recognized for its excellence through securing significant group research projects. We expect that through the opening of this research center, the education and research capabilities of the ERICA College of Pharmacy will grow to the next level and develop into the nation's top prestigious college of pharmacy."
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Research Center Director Yoo Hye-hyun stated, "We aim to contribute to maximizing drug therapeutic efficacy and minimizing side effects by elucidating changes in effective drug concentration, regulation of drug efficacy expression, and mechanisms caused by the human microbiome, developing microbiome markers and control platforms for personalized drug therapy and improving the success rate of new drug development."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.